Eucalyptus microcorys leaf extract derived HPLC-fraction reduces the viability of MIA PaCa-2 cells by inducing apoptosis and arresting cell cycle

Medicine and Dentistry

• High-Performance Liquid Chromatography 100%
• Programmed Cell Death 100%
• Cell Cycle 100%
• Pancreas Cancer 50%
• Phytochemical 50%
• Cytotoxicity 50%
• Tandem Mass Spectrometry 50%
• Gemcitabine 50%
• Electrospray Ionization 50%
• Pancreatic Cancer Cell Line 50%
• Antioxidant Capacity 50%
• Combination Therapy 25%
• Malignant Neoplasm 25%
• Monotherapy 25%
• Antioxidant 25%
• Poly ADP Ribose Polymerase 25%
• Phenol Derivative 25%
• Cell Cycle Checkpoint 25%
• Cell Cycle Arrest 25%
• IC50 25%
• Caspase 3 25%
• Reverse Phase High Performance Liquid Chromatography 25%
• Protein Bcl 2 25%
• Polyphenol 25%
• Defibrotide 25%
• Cell Cycle M Phase 25%
• Antiproliferative Activity 25%
• Procaspase 3 25%

Immunology and Microbiology

• Eucalypt 100%
• Cell Cycle 100%
• High Performance Liquid Chromatography 100%
• Cuniculidae 100%
• Programmed Cell Death 100%
• Antioxidant Activity 50%
• Cytotoxicity 50%
• Tandem Mass Spectrometry 50%
• Electrospray Ionization 50%
• Pancreatic Cancer Cell Line 50%
• Fractionation 25%
• IC50 25%
• Caspase 25%
• Bcl-2 25%
• Reverse Phase High Performance Liquid Chromatography 25%
• Antiproliferative Activity 25%
• Cell Cycle M Phase 25%
• Cell Cycle Arrest 25%
• Cell Cycle Checkpoint 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Pancreas Cancer 100%
• High Performance Liquid Chromatography 100%
• Eucalypt 100%
• Cuniculidae 100%
• Phytochemical 50%
• Antioxidant Capacity 50%
• Cytotoxicity 50%
• Gemcitabine 50%
• Malignant Neoplasm 25%
• Monotherapy 25%
• Antioxidant 25%
• Combination Therapy 25%
• IC50 25%
• Caspase 3 25%
• Polyphenol 25%
• Defibrotide 25%
• Antiproliferative Activity 25%
• Procaspase 3 25%
• Protein Bcl 2 25%
• Reverse Phase High Performance Liquid Chromatography 25%